Hyperpolarized helium-3 MR imaging of pulmonary function.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 15693659)

Published in Radiol Clin North Am on January 01, 2005

Authors

Masaru Ishii1, Martin C Fischer, Kiarash Emami, Abass Alavi, Zebulon Z Spector, Jiangsheng Yu, James E Baumgardner, Maxim Itkin, Stephen J Kadlecek, Jianliang Zhu, Michael Bono, Warren B Gefter, David A Lipson, Joseph B Shrager, Rahim R Rizi

Author Affiliations

1: Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, 4940 Eastern Avenue, A5W 595A, Baltimore, MD 21224, USA. mishii3@jhmi.edu

Articles by these authors

Akt stimulates aerobic glycolysis in cancer cells. Cancer Res (2004) 9.35

Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med (2008) 8.88

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81

Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53

Seasonal dynamics of previously unknown fungal lineages in tundra soils. Science (2003) 4.61

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16

Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. J Clin Oncol (2013) 3.46

Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med (2007) 3.08

Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg (2007) 2.73

Myosin gene mutation correlates with anatomical changes in the human lineage. Nature (2004) 2.69

18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med (2002) 2.45

Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology (2007) 2.30

Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data. Clin Nucl Med (2012) 2.22

Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol (2003) 2.20

Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest (2013) 2.19

miR-1 induces growth arrest and apoptosis in malignant mesothelioma. Chest (2013) 2.11

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07

Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer. J Nucl Med (2002) 2.05

Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg (2003) 2.05

Influence of inspiration to expiration ratio on cyclic recruitment and derecruitment of atelectasis in a saline lavage model of acute respiratory distress syndrome. Crit Care Med (2015) 1.95

Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging (2007) 1.93

Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol (2012) 1.92

Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr (2007) 1.92

Spatial and temporal heterogeneity of ventilator-associated lung injury after surfactant depletion. J Appl Physiol (1985) (2008) 1.88

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol (2011) 1.88

The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med (2012) 1.84

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol (2005) 1.84

Metabolic trade-offs and the maintenance of the fittest and the flattest. Nature (2011) 1.82

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer (2008) 1.81

Effects of abiotic factors on the phylogenetic diversity of bacterial communities in acidic thermal springs. Appl Environ Microbiol (2007) 1.81

Bronchoscopy for atelectasis in the ICU: a case report and review of the literature. Chest (2003) 1.76

Estimating population structure from AFLP amplification intensity. Mol Ecol (2010) 1.73

Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response? J Nucl Med (2003) 1.71

Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation. Ann Thorac Surg (2011) 1.70

Utility of FDG-PET scanning in lymphoma by WHO classification. Blood (2003) 1.69

Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol (2013) 1.66

Maintenance of end-expiratory recruitment with increased respiratory rate after saline-lavage lung injury. J Appl Physiol (1985) (2006) 1.64

PET in the management of urologic malignancies. Radiol Clin North Am (2004) 1.62

The IR RadLex project: an interventional radiology lexicon--a collaborative project of the Radiological Society of North America and the Society of Interventional Radiology. J Vasc Interv Radiol (2008) 1.61

Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med (2002) 1.60

Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET. J Neurol Sci (2006) 1.57

Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification. J Nucl Cardiol (2015) 1.53

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med (2009) 1.52

Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med (2009) 1.51

Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol (2007) 1.48

Is PET-CT the only option? Eur J Nucl Med Mol Imaging (2007) 1.48

Imaging the interaction of atelectasis and overdistension in surfactant-depleted lungs. Crit Care Med (2013) 1.48

Benign expectoration of a surgical clip through a pneumonectomy stump. J Thorac Cardiovasc Surg (2002) 1.48

The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. J Nucl Med (2007) 1.47

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thorac Cardiovasc Surg (2004) 1.46

Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient. J Heart Lung Transplant (2005) 1.46

Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease. J Appl Physiol (1985) (2006) 1.45

Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma (2004) 1.44

Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease. Eur J Nucl Med Mol Imaging (2013) 1.44

Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med (2009) 1.44

Metabolic activity of the tongue in obstructive sleep apnea. A novel application of FDG positron emission tomography imaging. Am J Respir Crit Care Med (2014) 1.43

Catamenial pneumothorax: optimal hormonal and surgical management. Eur J Cardiothorac Surg (2005) 1.42

A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer. Breast Cancer Res Treat (2009) 1.42

Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol (2009) 1.42

Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax (2012) 1.42

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement (2011) 1.41

Initial experience with ovarian vein embolization for the treatment of chronic pelvic pain syndrome. Isr Med Assoc J (2003) 1.41

Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am (2005) 1.40

Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer. Ann Thorac Surg (2013) 1.39

FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clin Nucl Med (2005) 1.38

When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging (2013) 1.37

Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging (2002) 1.37

Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected]. J Vasc Interv Radiol (2010) 1.36

Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med (2005) 1.33

Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun (2009) 1.31

18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med (2004) 1.31

Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol (2008) 1.30

In vivo detection of stem cells grafted in infarcted rat myocardium. J Nucl Med (2005) 1.30

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med (2005) 1.30

Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med (2006) 1.28

Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res (2012) 1.28

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat (2006) 1.27

Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders. Eur J Nucl Med Mol Imaging (2011) 1.27

A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. Crit Care Med (2015) 1.27

Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI-PET scanning. Neuroimage (2005) 1.26

Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab (2007) 1.25

FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging (2008) 1.25

Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med (2002) 1.23

Advances in magnetic resonance imaging of lung physiology. J Appl Physiol (1985) (2006) 1.21

Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med (2007) 1.21

A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. Cancer Cell (2013) 1.19

Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med (2004) 1.19

Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. Nucl Med Commun (2007) 1.19

Divergent evolutionary processes associated with colonization of offshore islands. Mol Ecol (2013) 1.16

Management of alveolar air leaks after pulmonary resection. Ann Thorac Surg (2010) 1.16

Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med (2004) 1.16

Percutaneous transhepatic venous access for hemodialysis. J Vasc Interv Radiol (2003) 1.16

Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse. Am J Respir Crit Care Med (2010) 1.16

Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev (2008) 1.16